Inolimomab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Inolimomab Usage And Synthesis

Uses

Inolimomab is an anti-interleukin-2 receptor (IL-2R) α chain monoclonal antibody. Inolimomab improves the survival rate in the early research of treating acute graft-versus-host disease (aGVHD)[1][2].

References

[1] Socié G, et al. A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD. Blood. 2017 Feb 2;129(5):643-649. DOI:10.1182/blood-2016-09-738625
[2] Pi?ana JL, et al. Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host disease. Biol Blood Marrow Transplant. 2006 Nov;12(11):1135-41. DOI:10.1016/j.bbmt.2006.06.010

Inolimomab(152981-31-2)Related Product Information

• afelimomab
• Plamotamab
• Cergutuzumab Amunaleukin
• Gancotamab
• Bectumomab
• Immunoglobulin G2/G4, anti-(human complement C5) (human-Mus musculus ALXN1210 heavy chain), disulfide with human-Mus musculus ALXN1210 κ-chain, dimer
• Siplizumab
• Plonmarlimab
• Olendalizumab
• Garetosmab